Yanfeng Hu

5.6k total citations · 1 hit paper
103 papers, 2.5k citations indexed

About

Yanfeng Hu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology. According to data from OpenAlex, Yanfeng Hu has authored 103 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 49 papers in Surgery and 45 papers in Gastroenterology. Recurrent topics in Yanfeng Hu's work include Gastric Cancer Management and Outcomes (80 papers), Gastrointestinal Tumor Research and Treatment (45 papers) and Metastasis and carcinoma case studies (28 papers). Yanfeng Hu is often cited by papers focused on Gastric Cancer Management and Outcomes (80 papers), Gastrointestinal Tumor Research and Treatment (45 papers) and Metastasis and carcinoma case studies (28 papers). Yanfeng Hu collaborates with scholars based in China, United States and Germany. Yanfeng Hu's co-authors include Jiang Yu, Guoxin Li, Liying Zhao, Yuming Jiang, Hao Liu, Tuanjie Li, Tingyu Mou, Zhiwei Zhou, Guoxin Li and Tuanjie Li and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Clinical Cancer Research.

In The Last Decade

Yanfeng Hu

97 papers receiving 2.5k citations

Hit Papers

ImmunoScore Signature 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfeng Hu China 26 1.5k 880 754 589 576 103 2.5k
Edwin P. M. Jansen Netherlands 23 1.2k 0.8× 451 0.5× 730 1.0× 427 0.7× 443 0.8× 51 2.3k
Daisuke Sakai Japan 22 963 0.6× 1.3k 1.5× 488 0.6× 356 0.6× 255 0.4× 121 2.3k
Young Soo Park South Korea 30 1.9k 1.3× 1.2k 1.3× 1.1k 1.5× 213 0.4× 949 1.6× 160 3.2k
Henk H. Hartgrink Netherlands 26 1.2k 0.8× 632 0.7× 791 1.0× 150 0.3× 349 0.6× 60 2.3k
Yoshihiro Nabeya Japan 27 1.0k 0.7× 886 1.0× 1.3k 1.8× 366 0.6× 147 0.3× 126 2.5k
Mizutomo Azuma Japan 25 1.2k 0.8× 927 1.1× 810 1.1× 212 0.4× 446 0.8× 91 2.2k
Alfonso De Stefano Italy 28 1.0k 0.7× 964 1.1× 835 1.1× 179 0.3× 325 0.6× 97 2.5k
Hiroshi Yabusaki Japan 22 2.6k 1.7× 1.3k 1.5× 2.0k 2.6× 367 0.6× 795 1.4× 142 3.6k
Tania Fleitas Spain 19 1.1k 0.7× 1.1k 1.3× 552 0.7× 126 0.2× 298 0.5× 58 2.3k
Naoto Gotohda Japan 31 1.2k 0.8× 1.8k 2.1× 1.7k 2.2× 177 0.3× 243 0.4× 188 3.5k

Countries citing papers authored by Yanfeng Hu

Since Specialization
Citations

This map shows the geographic impact of Yanfeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfeng Hu more than expected).

Fields of papers citing papers by Yanfeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfeng Hu. The network helps show where Yanfeng Hu may publish in the future.

Co-authorship network of co-authors of Yanfeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfeng Hu. A scholar is included among the top collaborators of Yanfeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfeng Hu. Yanfeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Li, Zhiwei, Xinhua Chen, Fengping Li, et al.. (2023). Clinical outcomes of conversion surgery following immune checkpoint inhibitors and chemotherapy in stage IV gastric cancer. International Journal of Surgery. 109(12). 4162–4172. 11 indexed citations
6.
Chen, Xinhua, Huimin Zhang, Minghao Wang, et al.. (2022). Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients. Frontiers in Immunology. 13. 783695–783695. 10 indexed citations
8.
Chen, Tao, et al.. (2019). A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine. BMC Genomics. 20(1). 846–846. 33 indexed citations
9.
Sun, Zepang, Hao Liu, Jiang Yu, et al.. (2019). Frequency and Prognosis of Pulmonary Metastases in Newly Diagnosed Gastric Cancer. Frontiers in Oncology. 9. 671–671. 14 indexed citations
10.
Xiong, Wenjun, Wei Wang, Haipeng Huang, et al.. (2019). Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer. Journal of Cancer. 10(18). 4357–4367. 10 indexed citations
11.
Jiang, Yuming, Jingjing Xie, Zhen Han, et al.. (2018). Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit. Clinical Cancer Research. 24(22). 5574–5584. 118 indexed citations
12.
Chen, Tao, Lili Xu, Liangying Ye, et al.. (2018). A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods. European Journal of Surgical Oncology. 45(6). 1109–1114. 17 indexed citations
13.
Wang, Hao, Tingyu Mou, Hao Chen, et al.. (2018). Long-term outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for gastric cancer: a 10-year single-institution experience. Surgical Endoscopy. 33(1). 135–144. 8 indexed citations
14.
Ye, Gengtai, Jiang Yu, Liying Zhao, et al.. (2017). MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer. Theranostics. 7(13). 3338–3353. 71 indexed citations
15.
Liao, Guanqun, Tao Chen, Xiaolong Qi, et al.. (2017). Laparoscopic management of gastric gastrointestinal stromal tumors: A retrospective 10-year single-center experience. World Journal of Gastroenterology. 23(19). 3522–3522. 26 indexed citations
16.
Li, Tuanjie, Yuming Jiang, Yanfeng Hu, et al.. (2016). Interleukin-17–Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric Cancer. Clinical Cancer Research. 23(6). 1575–1585. 130 indexed citations
17.
Yu, Jiang, et al.. (2015). Laparoscopic distal gastrectomy with D2 dissection for advanced gastric cancer. ASVIDE. 1(1). 2 indexed citations
18.
Li, Guoxin, Tingyu Mou, Yanfeng Hu, et al.. (2013). Laparoscopic total gastrectomy with spleen-preserving splenic hilar (No. 10) lymph nodes dissection. 1(1). 10–12. 2 indexed citations
19.
Li, Guoxin, Tingyu Mou, Jiang Yu, Yanan Wang, & Yanfeng Hu. (2012). Laparoscopic pancreas- and spleen-preserving splenic hilar lymph nodes dissection through retropancreatic approach in radical gastrectomy for advanced gastric cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 11(1). 58–60.
20.
Mou, Tingyu, Yanfeng Hu, Jiang Yu, et al.. (2012). Clinical value of transorally inserted anvil in esophagojejunostomy after laparoscopic total gastrectomy for gastric cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 11(3). 211–214. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026